跳至主要内容
临床试验/NCT07292922
NCT07292922招募中不适用

Digital-supported Orofacial Myofunctional Therapy in Subjects With Obstructive Sleep Apnoea: A Pilot Randomised Control Trial

Hong Kong Metropolitan University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月5日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Programme satisfaction

研究概览

简要总结

This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity.

Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30).

Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.

详细描述

This pilot study investigates the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative approach that integrates facial recognition technology with evidence-based orofacial exercises tailored for individuals with mild to moderate obstructive sleep apnoea (OSA). Grounded on Self-Determination Theory, the d-MFT program aims to strengthen oropharyngeal muscles, enhance airway function, and alleviate OSA severity and snoring (if any). The intervention consists of five 30-minute sessions and two follow-up phone calls conducted over three months, all delivered through a dedicated mobile application that provides real-time feedback and tracks adherence.

The primary objectives of this research are twofolds: first, to evaluate whether d-MFT effectively reduces OSA severity and associated symptoms, and second, to identify barriers and facilitators to its implementation in real-world settings. Participants who receive the d-MFT intervention are expected to show greater improvements in OSA severity, sleep-related symptoms, and overall quality of life compared to those in the control group.

This randomized controlled trial will recruit 60 participants, divided into two groups of 30 each, all diagnosed with mild to moderate OSA (apnoea-hypopnea index [AHI] of 5-30 events per hour). Individuals with severe comorbidities or a history of OSA-related surgery will be excluded. The intervention group will engage with the d-MFT app daily for three months, while the control group will continue their usual care before transitioning to the intervention after the assessment.

Outcomes will be measured at baseline and after three months. Objective assessments will include polysomnography to evaluate the apnoea-hypopnea index, oxygen desaturation index, and snoring severity. Subjective evaluations will be conducted using standardized questionnaires such as the Epworth Sleepiness Scale, Insomian Severity Index, and Functional Outcomes of Sleep Questionnaire, providing insights into daytime sleepiness, sleep quality, and quality of life. Additionally, oropharyngeal muscle function will be assessed through tongue pressure measurements. Adherence to the d-MFT program will be monitored using electronic logs within the app.

Feasibility and acceptability will be assessed through semi-structured interviews that explore participants' experiences, levels of satisfaction, and perceived barriers to adherence. For quantitative data analysis, linear mixed-effects models will be utilized to account for repeated measurements and potential confounders, while qualitative data will be analyzed through thematic content analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 years and above
  • Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour
  • Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments
  • Body Mass Index less than 30 kg/m2

排除标准

  • Presence of obstructive nasal disease or significant nasal obstruction
  • Unstable mental health issues
  • History of stroke
  • Unstable chronic respiratory, cardiac, neurological conditions
  • Inability to provide informed consent
  • Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea

研究组 & 干预措施

Waitlist Control Group

No Intervention

The waitlist control group will not receive any intervention within the study period

d-MFT Intervention Group

Experimental

The d-MFT intervention group will participate in a 3-month digital-support Myofunctional Therapy program. This innovative program is designed to ensure proper exercise performance, enhance adherence, and provide real-time feedback to patients.

干预措施: Digital-supported Orofacial Myofunctional Therapy (Behavioral)

结局指标

主要结局

Programme satisfaction

时间窗: month 3

Outcome-based questions on satification on the program

Change in oxygen saturation

时间窗: Baseline and month 3

Measured by sleep test

次要结局

  • Change in respiratory Indices(Baseline, month 3)
  • Change in snoring(Baseline, month 3)
  • Change in sleep quality(Baseline, month 3)
  • Change in daily function(Baseline, month 3)
  • Change in oropharyngeal muscle function(Baseline, month 3)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Agnes LAI Yuen Kwan

Associate Professor

Hong Kong Metropolitan University

研究点 (1)

Loading locations...

相似试验